|Year : 2016 | Volume
| Issue : 3 | Page : 50-56
The role of dexmedetomidine in fast-track extubation for closed congenital heart surgery in children: a randomized double-blinded placebo-controlled trial
Passaint H Fahim, Mai A Madkour
Department of Anesthesia and Intensive Care, Cairo University, Cairo, Egypt
|Date of Submission||30-Apr-2016|
|Date of Acceptance||20-Nov-2016|
|Date of Web Publication||17-Feb-2017|
Mai A Madkour
3 Mohamed Salem st, Alharam, Giza, postal code 12555
Source of Support: None, Conflict of Interest: None
Background The definition of early extubation is not well-established; some authors extended its time to 24 h postoperatively. In our study, we tried to extubate the patients by the end of the surgery. We investigated the role of dexmedetomidine use during induction of anesthesia in the improvement of outcomes with fast-track extubation in children undergoing cardiac surgery. We assumed that the use of dexmedetomidine will help in extubating the patients at the end of operation with decreased use of inhalational anesthetic and fentanyl, thus improving oxygenation and decreasing the need for analgesia postoperatively.
Patients and methods A study was conducted in a population of 84 pediatric patients scheduled for closed congenital heart surgery. Patients were randomly allocated to two groups: group D (42 patients), which received a single dose of dexmedetomidine 0.4 mg/kg over 10 min in the induction of anesthesia, and group C (42 patients), which received normal saline. Both groups were compared in relation to percentage of extubated patients by the end of the surgery as primary outcome. Hemodynamics (mean arterial blood pressure and heart rate), sevoflurane consumption, fentanyl consumption, incidence of postoperative infection, and length of ICU stay were recorded. Arterial blood gases were analyzed before extubation and in the ICU 1 and 3 h after transfer to the ICU.
Results Compared with the control group, group D showed lower intraoperative sevoflurane and fentanyl consumption (14.2±2.9 vs. 37.8±24.1, P<0.01; 48±12.5 vs. 85.2±43.2, P<0.01). The blood pressure at T1 and T2 showed a statistically significant decrease compared with baseline (P=0.05 and 0.01, respectively) and heart rate showed a significant decrease (P=0.05) at T1 and (P<0.01) at T2. Group D showed a higher incidence of successful extubation (64 vs. 26.7%, P=0.04) and higher pO2 after extubation (82±28.45 vs. 68±0.23, P=0.04). The length of ICU stay was lower in group D (1.8±0.8) compared with 5.5±3.2 in the control group (P<0.01), and the incidence of postoperative infections was lower in group D compared with group C (29.4 vs. 65.2%, P=0.04).
Conclusion Adding dexmedetomidine as an adjuvant to induction of anesthesia in children undergoing congenital heart surgery improved the success of extubation, the oxygenation, and decreased the length of hospital stay.
Keywords: congenital heart surgery, dexmedetomidine, early extubation
|How to cite this article:|
Fahim PH, Madkour MA. The role of dexmedetomidine in fast-track extubation for closed congenital heart surgery in children: a randomized double-blinded placebo-controlled trial. Egypt J Cardiothorac Anesth 2016;10:50-6
|How to cite this URL:|
Fahim PH, Madkour MA. The role of dexmedetomidine in fast-track extubation for closed congenital heart surgery in children: a randomized double-blinded placebo-controlled trial. Egypt J Cardiothorac Anesth [serial online] 2016 [cited 2017 Dec 14];10:50-6. Available from: http://www.ejca.eg.net/text.asp?2016/10/3/50/200281
| Introduction|| |
Advantages of early extubation include avoidance of airway irritation, edema, accidental extubation, pulmonary hypertensive crisis during suction from endotracheal tube, chest infection, and pneumothorax related to prolonged ventilation; other advantages include early mobilization of the patient, early ICU discharge, and reduced costs .
Surgery for congenital cardiac disease always required mechanical ventilation that is continued postoperatively in the ICU (which may extend to days). Early extubation in the operating room (OR) was attempted in our study immediately in the OR after surgery. The definition of early extubation is not well-established; some authors extended its time to 24 h postoperatively .
Many anesthetic techniques can be used for fast-track extubation in pediatric cardiac patients, such as the use of a large dose of opioids, neuroaxial technique, and nonopioid analgesia. The use of a short-acting α2 agonist dexmedetomidine as an induction agent can help in extubating the patients at the end of operation by decreasing the use of inhalational anesthetics and narcotic use as well as improving oxygenation, thus helping extubation in OR and avoiding the unnecessary delay in the discharge from the ICU.
Patients were considered for extubation at the end of surgery if they were hemodynamically stable and having satisfactory arterial blood gases (ABGs).
| Aim of the work|| |
The aim of this study was to evaluate the effect of dexmedetomidine as an adjuvant drug during the induction of anesthesia on the fast-track technique in closed pediatric cardiac surgery.
| Patients and methods|| |
This randomized controlled double-blinded study was conducted in Cairo University Hospitals after obtaining the ethical committee approval. Written informed consent was obtained from the guardians of the children. Randomization was carried out using a computer-generated sequence, and concealment was carried out using opaque envelopes. This study was conducted from December 2014 to May 2015 (18 months). Patients were randomly allocated to two equal groups of 42 patients each. Pediatric patients with congenital heart diseases (otherwise healthy) who were older than 2 months and weighed more than 6 kg and scheduled to undergo closed heart surgery were included in the study. Patients requiring preoperative mechanical ventilation or high inotropic support (>0.1 mcg/kg/h adrenaline and 15 mcg/kg/h dobutamine) or those sensitive to any of the drugs used in the study were excluded from the study.
Patients were allocated on the morning of surgery to two groups: group D (42 patients), which received dexmedetomidine 0.4 mcg/kg administered over 10 min during the induction of anesthesia, and group C (42 patients), which received saline. All operations were performed by one surgeon.
The anesthesiologist interviewed the guardians and examined the patients. All patients were subjected to routine investigations, which included complete blood count, coagulation profile, liver function tests, renal function tests, blood grouping, chest radiography, recent echocardiography, and angiography if available.
Children in both groups received midazolam 0.3 mg/kg intramuscularly and atropine 0.02 mg/kg intramuscularly 10 min as premedication induction.
Induction of anesthesia in both groups was carried out using sevoflurane and fentanyl 1–5 μg/kg. Atracurium 0.5 mg/kg was administered to facilitate endotracheal intubation and repeated intraoperatively as required to maintain muscle relaxation. Anesthesia was maintained using sevoflurane 0.3–1.5% in oxygen–air mixture (1 : 1 ratio to keep end-tidal CO2 between 30 and 35). Dexmedetomidine 0.4 mg/kg diluted with normal saline in 10 ml was administered over 10 min in group D (the dexmedetomidine group). Group C (the control group) was administered 10 ml of normal saline during induction to assure double-blinded study. A central venous line was inserted and an arterial line for invasive blood pressure monitoring. The incremental doses of fentanyl were given if needed at a dose of 1–2 mcg/kg, and atracurium infusion was carried out at a rate of 0.5 mg/kg/h to maintain muscle relaxation. The use of inotropes was guided by the patient’s hemodynamics after surgical repair.
At the end of the operation, ABG was analyzed and accordingly the effects were reversed with the intravenous administration of atropine, 0.01 mg/kg, and neostigmine, 0.05 mg/kg, or remained ventilated. Ketorolac suppository 50 mg/kg was administered for postoperative analgesia. Patients were extubated when conscious, breathing with adequate tidal volume and adequate oxygenation (75–80% in cyanotic patients and 95% in acyanotic patients at FiO2 0.3), and hemodynamically stable. The patient was transferred to the surgical ICU adjacent to the OR.
Both groups were compared in relation to percentage of extubated patients by the end of the surgery as primary outcome. Mean arterial blood pressure and heart rate were measured at baseline, 10 min after induction (T1), and 1 h after induction (T2). Sevoflurane consumption was calculated at the end of operation with Maquet anesthesia machine using fixed fresh gas flow of 1 l. Fentanyl consumption, incidence of postoperative infection, and ICU stay were also recorded.
ABGs (pH, pO2, and CO2) were analyzed before extubation and in the ICU 1 and 3 h after transfer to the ICU.
SPSS (SPSS IBM company USA, Chicago) (version 15) and Microsoft Excel 2016 were used for analysis. Categorical data were presented as frequency (%) and analyzed using the χ2-test. Continuous data were presented as mean and SDs and analyzed using the unpaired t-test and the Mann–Whitney test as appropriate. Repeated measures were analyzed using the analysis of variance test for repeated measures.
A P value less than or equal to 0.05 was considered statistically significant and P value less than or equal to 0.01 was considered highly significant.
The primary outcome in our study was the incidence of successful extubation. We calculated the sample size using Medcalc software to detect a difference of 35% between the two study groups. Having a study power of 80% and an α error of 0.05, a minimum number of 36 patients was needed for each group. We increased the number by 20% to be 42 patients per group to compensate for possible dropouts .
| Results|| |
Among 84 patients included in the study, no significant differences were reported in demographic data or type of surgery ([Table 1]).
The mean arterial blood pressure at T1 and T2 showed a statistically significant decrease compared with baseline (P<0.01 and 0.01, respectively) and heart rate showed a significant decrease (P=0.05) at T1 and a highly significant decrease at T2 (P<0.01) in the dexmedetomidine group ([Table 2] and [Figure 1] and [Figure 2]).
|Table 2 Difference between two groups in mean heart rate and mean blood pressure at baseline, T1, T2|
Click here to view
|Figure 1 Significant decrease of mean arterial blood pressure at T1 (p=0.05),and highly significant decrease at T2 (p<0.01) in dexmedetomidine group.|
Click here to view
|Figure 2 Significant decrease of heart rate at T1 (p=0.05) and highly significant decrease at T2 (p<0.01) in dexmedetomidine group.|
Click here to view
Extubation data (arterial blood gases and percent of extubation)
In this study, the pH before extubation in the control group showed a significant decrease, with a mean of 7.33±0.046 compared with 7.35±0.069 in the study group (P=0.05). There was a highly significant decrease 1 and 3 h after extubation in the study group compared with the control group (P=0.01) ([Table 3] and [Figure 3],[Figure 4],[Figure 5]).
|Table 3 Differences in pH, pO2, pCO2 and percentage of extubated patients in both groups|
Click here to view
|Figure 3 Significant increase at pre-extubation time and one hour post extubation (p=0.05),(p=0.04)in dexmedetomidine group.|
Click here to view
|Figure 4 Significant decrease of pCO2 in dexmedetomidine group one hour post extubation (p=0.02).|
Click here to view
|Figure 5 Percentage of successful extubation in Dex group compared to control group.|
Click here to view
pCO2 showed a significant decrease 1 h after extubation in group D compared with group C (39±5.4 vs. 46±7.04, P=0.02). pO2 showed a significant increase in the dexmedetomidine group compared with the control group both before extubation (80±3.75 vs. 70±0.13, P=0.05) and 1 h after extubation (82±28.45 vs. 68±0.23, P=0.04). pCO2 change was not statistically significant even after 3 h of extubation.
The percentage of successful extubation was 64% in the dexmedetomidine group compared with 26.7% in the control group, with a significance of 0.04.
Intraoperative fentanyl and sevoflurane consumption
The mean consumption of fentanyl in the dexmedetomidine group was 48±12.5 μg/kg compared with 85.2±43.2 μg/kg in the control group (P<0.01). The mean consumption of sevoflurane in the dexmedetomidine group was 14.2±2.9 ml compared with 37.8±24.1 ml in the control group (P<0.01) ([Table 4] and [Figure 6] and [Figure 7]).
|Table 4 Difference in fentanyl and sevoflurane consumption between both groups|
Click here to view
|Figure 6 Comparison between mean fentanyl consumption in µg in both groups.|
Click here to view
|Figure 7 Comparison between the mean consumption of Sevoflurane in ml in both groups.|
Click here to view
Ketorolac was used for postoperative analgesia. Time to first postoperative dose was recorded in both groups. The time to first dose in the dexmedetomidine group was after 5.5±1.67 h and after 3.2±1.09 h in the control group with a significant difference (P=0.05) ([Table 5] and [Figure 8] and [Figure 9]).
|Table 5 Difference between time needed for first dose ketorolac, incidence of post operative infections and mean ICU stay|
Click here to view
|Figure 8 Incidence of postoperative infections (29.4% in compared to 65.2 % in control group with p value 0.04).|
Click here to view
The percentage of postoperative infections in the dexmedetomidine group was 29.4% compared with 65.2% in the control group (P=0.04). The mean ICU stay was shorter in the dexmedetomidine group (1.8±0.8) compared with that in the control group (5.5±3.2) (P<0.01).
Mortality occurred in two cases in the control group compared with one case in the dexmedetomidine group and was due to postoperative infection and sepsis.
| Discussion|| |
Dexmedetomidine improved the success of fast-track extubation in pediatric patients undergoing closed cardiac surgery. The percentage of successful extubation was 64% in the dexmedetomidine group compared with 26.7% in the control group, with a significance of 0.04.
Our attempt to facilitate early extubation using a single dose of dexmedetomidine decreased the doses of intraoperative inhalational anesthetic and narcotics, as the mean consumption of sevoflurane in the dexmedetomidine group was 14.2±2.9 ml compared with 37.8±24.1 ml in the control group (P<0.01) and the mean consumption of fentanyl in the dexmedetomidine group was 48±12.5 μg/kg compared with 85.2±43.2 μg/kg in the control group (P<0.01).
Dexmedetomidine is a potent, highly selective, and specific α2-adrenoreceptor agonist, which lowers blood pressure and heart rate. It can be used as a sedative, analgesic, anxiolytic, and an adjuvant to general anesthesia ,.
Extubation inside the OR in pediatric congenital heart surgeries in our country is not a common practice. To our knowledge, we were the first to use dexmedetomidine as a small single dose in closed heart surgery to help extubation by the end of the surgery.
Patients were extubated when they were conscious, breathing with adequate tidal volume and adequate oxygenation (75–80% in cyanotic patients and 95% in acyanotic patients at FiO2 0.3) and hemodynamically stable, and the doses of inotropes were guided by the patient’s hemodynamics after surgical repair.
We concluded that the use of a single dexmedetomidine reduces the anesthetic requirements with minimal effect on the hemodynamics due to central and peripheral mechanisms by reduction in sympathetic tone and reduction in circulating catecholamines affecting mean arterial blood pressure and heart rate . In the case of a single minimal dose use less than 1 mcg/kg, the initial transient increase in blood pressure response can be attenuated with slow infusion over 10 min, thus decreasing the incidence of complications such as hypotension, which if happened can be treated with vasopressor and fluids. Bradycardia which is more common and more serious as cardiac output is more dependable on heart rate in pediatrics, can be treated by atropine.
In addition to its analgesic effect, which is attributed to the activation of α2 adrenoreceptors in the spinal cord, it lowers the transmission of nociceptive and inhibits the release of substance p from the dorsal horn . Its sedative effect intraoperatively helps in minimizing the anesthetic requirement and narcotics as well. All these can help in a smooth emergence and easy extubation guided by satisfactory ABGs on FiO2 (0.3) as in our study.
The single early dose use of the dexmedetomidine in our study can minimize its postoperative sedation effect (compared with dexmedetomidine infusion), having no respiratory depressive effect. This was proved by one of the important detectors, which is satisfactory postoperative blood gases. The postextubation blood gases were measured 1 h after extubation. There was a significant increase in pO2 in the dexmedetomidine group 1 h after extubation compared with the control group (P=0.04) and a decrease in pCO2 in the dexmedetomidine group 1 h after extubation (P=0.17) .
One of the famous factors that was known to affect the ventilation in pediatrics was the opioid-based anesthesia . Thus, we believed that the initial single small dose of dexmedetomidine 0.4 mg/kg/min lowered the intraoperative fentanyl requirements, thus making early extubation easier, especially in low-weight patients, as dexmedetomidine had an analgesic effect as well as prolonged duration of postoperative need for analgesia. Time to first ketorolac dose was 5.5±1.67 h in the dexmedetomidine group compared with 3.2±1.09 h in the control group, with a significant difference (P=0.05).
An interesting finding in our study is that early extubation decreased the risk for postoperative infection in the ICU, which is mostly due to the absence of ventilator-acquired chest infections in this group. This decreases the ICU stay, which is the goal of early extubation. This in turn decreases hospital stay, thus decreasing the cost. Other potential advantages of early extubation include fewer airway complications such as (a) tracheal stenosis, ventilator-associated complications, (b) parent’s reduced stress, (c) reduced amount of sedatives and associated hemodynamic compromise, (d) more rapid patient mobilization, and (e) reduced costs .
The pathology of the patient did not affect the success of extubation. Even the patients with single ventricle pathology, such as those undergoing Glenn or Fontan procedures, were good candidates for extubation. A study of 50 patients undergoing bidirectional Glenn or Fontan procedures who were early extubated showed improved hemodynamics (improved pulmonary artery pressure and increased cardiac index) compared with pre-extubation values .
Costs play an important role in conducting this study. In a hospital with very high flow of patients and limited resources, decreasing ICU stay significantly and consequently reducing the hospital stay for a category of cardiac surgery patients is highly beneficial. In 1980, Barash et al.  published their own experience with early extubation in 197 patients less than 3 years of age including neonates; 61% were successfully extubated in OR. The authors mentioned that any technique that allows maximal use of resources without jeopardizing patient safety is welcome. This statement seems even more appropriate at present, with cost issues being a greater concern today than 30 years ago .
Control of postoperative pain was achieved with ketorolac, which is reported to relieve postoperative pain in cardiac surgery despite risk for bleeding . This point was important in extubated patients to avoid the use of high doses of opioids, which may compromise ventilation postoperatively. However, other researchers have adopted the use of regional anesthesia such as caudal epidural morphine 50–75 μg/kg to diminish postoperative pain .
An additive effect of dexmedetomidine is the analgesic effect, which increased the time needed for the first dose of ketorolac postoperatively compared with the control group.
In agreement with our study, Shruthi et al.  showed that the use of 0.5 mcg/kg of dexmedetomidine in general surgery at intubation before skin incision can attenuate the hemodynamic changes at extubation without the sedative effect of dexmedetomidine, thus making the postoperative extubation very smooth.
In contrast to our study, the study by Guler et al.  on emergence agitation stated that time to extubation and emergence were prolonged significantly, due to a higher dose of dexmedetomidine used.
A study by Hall et al. demonstrated that dexmedetomidine decreased minimum alveolar concentration of halothane by 90% in rats  due to its greater specificity to α2 adrenoceptors and its analgesic effect compared with clonidine, which decreased minimum alveolar concentration by 48% ,.
Settings in surgery for congenital heart diseases in which fast-tracking cannot be considered safe include all patients who are hemodynamically unstable, coagulopathic patients, or patients who do not meet generally accepted extubation criteria detected with pre-extubation ABGs .
Another study by Lawrence et al.  demonstrated that Hospital and ICU costs for patients who were extubated in the OR at the end of the procedure were 31 and 35% lower, respectively, compared with costs for children who were extubated later in the ICU. There was no difference in early morbidity or in survival rates with a follow-up of more than 12 months. However, in our study there was a marked reduction in infections in the ICU, which goes side by side with the absence of postoperative ventilation in the early extubation group.
Our study was limited to patients undergoing closed heart surgery. We recommend that future studies be conducted on patients undergoing open heart surgery.
| Conclusion|| |
Early extubation for congenital cardiac surgery is an old concern. However, safety of the patients was the main obstacle for achieving it. Adding a single small dose of dexmedetomidine as an induction agent helps to achieve a better outcome with pain relief and better respiratory function both intraoperatively and postoperatively without detected complications.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Mittnacht AJ, Thanjan M, Srivastava S, Joashi U, Bodian C, Hossain S et al.
Extubation in the operating room after congenital heart surgery in children. J Thorac Cardiovasc Surg 2008; 136:88–93.
Davis S, Worley S, Mee RB, Harrison AM. Factors associated with early extubation after cardiac surgery in young children. Ped Crit Care Med 2004; 5:63–68.
Le KN, Moffett BS, Ocampo EC, Zaki J, Mossad EB. Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med 2011; 37:686–690.
Kaukinen S, Pyykkö K. The potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol Scand 1979; 23:107–111.
Hall JE, Uhrich TD, Barney JA, Arian S, Erbert TJ et al.
Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699–705.
Vickery RG, Sheridan BC, Segal IS, Maze M, Mervyn MB. Anesthetic and hemodynamic effects of the stereoisomers of medetomidine, an alpha 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988; 67:611–615.
Kanda H, Kunisawa T, Kurosawa A, Nagashima M, Suzuki A, Takahata O et al.
Effect of dexmedetomidine on anesthetic requirements in cardiovascular surgery. Jpn J Anesthesiol 2009; 58:1496–1500.
Laussen PC, Reid RW, Stene RA, Pare DS, Hickey PR, Jonas RA et al.
Tracheal extubation of children in operating room after atrial septal defect repair as a part of a clinical practice guideline. Anesth Analg 1996; 82:988–993.
Lofland JK. The enhancement of hemodynamic performance in Fontan circulation using pain free spontaneous ventilation. Eur J Cardiothorac Surg 2001; 20:114–118.
Barash PG, Lescovich F, Katz JD, Norman XX, Stansel HC et al.
Early extubation following pediatric cardiothoracic operations: a viable alternative. Ann Thorac Surg 1980; 29:228–233.
Mittnacht XX, Hollinger I. Fast tracking in pediatric cardiac surgery − The current standing. Ann Card Anesth 2010; 13:2.
Gupta A, Daggett C, Drant S, Rivero N, Lewis A Prospective randomized trial of ketorolac after congenital heart surgery. J Cardiothorac Vasc Anesth 2004; 18:454–457.
Rosen KR, Rosen DA. Caudal epidural morphine for control of pain following open heart surgery in children. Anesthesiology 1997; 70:418–421.
Shruthi AH, Nethra SS, Sudheesh K, Devika Rani D, Raghavendra Rao RS. Effect of dexmedetomidine on hemodynamic parameters during extubation. A prospective randomized double blind study. Middle East J Anaesthesiol 2016; 23:457–463.
Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anesthesiol Scand 2005; 49:1088–1091.
Akhtar MI, Hamid M, Minai F, Wali AR, Anwar-ul-haq M, Aman-Ullah M et al.
Safety profile of fast-track extubation in pediatric congenital heart disease surgery patients in a tertiary care hospital of a developing country: an observational prospective study. J Anaesthesiol Clin Pharmacol 2014; 30:355–359.
Lawrence EJ, Nguyen K, Morris SA, Hollinger I, Graham DA, Jenkins KJ et al.
Economic and safety implications of introducing fast tracking in congenital heart surgery. Circ Cardiovasc Qual Outcomes 2013; 6:201–207.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]